产品详情
中文名称:(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮 | 英文名称:(5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione |
CAS:5696-51-5 | 纯度规格: 99%+HPLC |
产品类别: 黄金产品 |
2024-08-09
(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
(5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
1KG/RMB;10KG/RMB
99%+HPLC
黄金产品
中文名称:(5R,8R,9R,10S,13S,14S)-13-甲基十二氢-1H-环戊二烯并[a]菲-3,17(2H,4H)-二酮
英文名称:(5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione
CAS:5696-51-5
其它信息:纯度:99%+HPLC | 包装信息:1KG;15KG;25KG;50KG;按需包装
备注: 优势产品,工厂直供。
关键字: 5696-51-5;
公司简介
Founded by a group of veterans from the US biopharmaceutical industry in 2010, P&T is now a leading Shanghai-based CRO company providing drug discovery and development services worldwide
成立日期 |
2014-07-30
(11年)
|
注册资本 |
200万人民币
|
员工人数 |
50-100人 |
年营业额 |
¥ 5000万-1亿 |
主营行业 |
医药中间体,原料药 |
经营模式 |
工厂,定制 |